Skip to Main Content

Author Details

Bernd Schnabl
University of California San Diego
2001
229
72
PMIDPaper TitleJournal TitlePublished Year
37356804Bile acid and nonalcoholic steatohepatitis: Molecular insights and therapeutic targets.J Adv Res2024
36631002Any alcohol use in NAFLD patients is associated with significant changes to the intestinal virome.Hepatology2023
37527781Gut Microbiome-Centered Therapies for Alcohol-Associated Liver Disease.Semin Liver Dis2023
37553429A metabolite from commensal Candida albicans enhances the bactericidal activity of macrophages and protects against sepsis.Cell Mol Immunol2023
37060262Serum keratin 18-M65 levels detect progressive forms of alcohol-associated liver disease in early noncirrhotic stages.Alcohol Clin Exp Res (Hoboken)2023
37290589Intestinal clock modulates rhythmic hepatic metabolism.J Hepatol2023
37058088Toll-like receptor 2 activation in monocytes contributes to systemic inflammation and alcohol-associated liver disease in humans.Hepatol Commun2023
37021791Global and national prevalence of nonalcoholic fatty liver disease in adolescents: An analysis of the global burden of disease study 2019.Hepatology2023
37316582The gut-liver axis and gut microbiota in health and liver disease.Nat Rev Microbiol2023
37183549Acute alcohol-associated hepatitis: Latest findings in non-invasive biomarkers and treatment.Liver Int2023
37475473Fecal virome transplantation is sufficient to alter fecal microbiota and drive lean and obese body phenotypes in mice.Gut Microbes2023
37198098Fecal cytolysin does not predict disease severity in acutely decompensated cirrhosis and acute-on-chronic liver failure.Hepatobiliary Pancreat Dis Int2023
36626635Can a mucosal microbiota signature predict disease severity, survival, and disease recurrence in PSC?Hepatology2023
36811393IgY antibodies against cytolysin reduce ethanol-induced liver disease in mice.Hepatology2023
36690432Hepatic pIgR-mediated secretion of IgA limits bacterial translocation and prevents ethanol-induced liver disease in mice.Gut2023
36807831Differences in Bacterial Translocation and Liver Injury in Ethanol Versus Diet-Induced Liver Disease.Dig Dis Sci2023
36778328Fecal virome transplantation is sufficient to alter fecal microbiota and drive lean and obese body phenotypes in mice.bioRxiv2023
36871955Engineered bacteria producing aryl-hydrocarbon receptor agonists protect against ethanol-induced liver disease in mice.Alcohol Clin Exp Res (Hoboken)2023
36706195Malassezia restricta promotes alcohol-induced liver injury.Hepatol Commun2023
36565724Fungal infections and the fungal microbiome in hepatobiliary disorders.J Hepatol2023
36893735Candida albicans-specific Th17 cell-mediated response contributes to alcohol-associated liver disease.Cell Host Microbe2023
34010477A semiparametric model for between-subject attributes: Applications to beta-diversity of microbiome data.Biometrics2022
35605662Selective PPARδ agonist seladelpar suppresses bile acid synthesis by reducing hepatocyte CYP7A1 via the fibroblast growth factor 21 signaling pathway.J Biol Chem2022
35792761Liver cirrhosis and immune dysfunction.Int Immunol2022
35602917Systemic Activin Is Elevated in Patients With Severe Alcoholic Hepatitis.Gastro Hep Adv2022
35368152Intestinal virome in patients with alcohol use disorder and after abstinence.Hepatol Commun2022
35629937Lipidomics for the Prediction of Progressive Liver Disease in Patients with Alcohol Use Disorder.Metabolites2022
35589257Promises of microbiome-based therapies.J Hepatol2022
36536957Sarcopenia-related gut microbial changes are associated with the risk of complications in people with cirrhosis.JHEP Rep2022
36422247Correlation between Serum Steroid Hormones and Gut Microbiota in Patients with Alcohol-Associated Liver Disease.Metabolites2022
36001995Metabolic Injury of Hepatocytes Promotes Progression of NAFLD and AALD.Semin Liver Dis2022
35941112Acetate reprograms gut microbiota during alcohol consumption.Nat Commun2022
35919965Duodenal CD8+ T resident memory cell apoptosis contributes to gut barrier dysfunction and microbial translocation in early alcohol-associated liver disease in humans.Aliment Pharmacol Ther2022
36157139Gut Microbiome and Alcohol-associated Liver Disease.J Clin Exp Hepatol2022
36287053Inexpensive, Accurate, and Stable Method to Quantitate Blood Alanine Aminotransferase (ALT) Levels.Methods Protoc2022
33516950Trajectory of Serum Bilirubin Predicts Spontaneous Recovery in a Real-World Cohort of Patients With Alcoholic Hepatitis.Clin Gastroenterol Hepatol2022
35075592Colesevelam ameliorates non-alcoholic steatohepatitis and obesity in mice.Hepatol Int2022
35220659Effect of rifaximin on infections, acute-on-chronic liver failure and mortality in alcoholic hepatitis: A pilot study (RIFA-AH).Liver Int2022
35042252Liver specific, systemic and genetic contributors to alcohol-related liver disease progression.Z Gastroenterol2022
34995410Roles for the mycobiome in liver disease.Liver Int2022
35202510Development of a Robotic Shear Wave Elastography System for Noninvasive Staging of Liver Disease in Murine Models.Hepatol Commun2022
34992134Clinical, histological and molecular profiling of different stages of alcohol-related liver disease.Gut2022
35050163Machine Learning Applied to Omics Datasets Predicts Mortality in Patients with Alcoholic Hepatitis.Metabolites2022
34896404The fecal mycobiome in non-alcoholic fatty liver disease.J Hepatol2022
35336897Immune Response of an Oral <i>Enterococcus faecalis</i> Phage Cocktail in a Mouse Model of Ethanol-Induced Liver Disease.Viruses2022
35294872RORγt phosphorylation protects against T cell-mediated inflammation.Cell Rep2022
34734271Role of the Gut Microbiota in Parenteral Nutrition-Associated Liver Disease: From Current Knowledge to Future Opportunities.J Nutr2022
34782783Bacteriophages and their potential for treatment of gastrointestinal diseases.Nat Rev Gastroenterol Hepatol2022
34454169Aryl Hydrocarbon Receptor Deficiency in Intestinal Epithelial Cells Aggravates Alcohol-Related Liver Disease.Cell Mol Gastroenterol Hepatol2022
32553670The selective PPAR-delta agonist seladelpar reduces ethanol-induced liver disease by restoring gut barrier function and bile acid homeostasis in mice.Transl Res2021
  • 1 - 50 of 229

Recommended Authors

Benedikt Hild
University Hospital Essen
Career Start Year 2017
Number of shared co-authors 1
Zhengtao Liu
Shulan International Medical College, Zhejiang Shuren University
Career Start Year 2012
Number of shared co-authors 0
Vaibhav Upadhyay
University of California San Francisco
Career Start Year 2012
Number of shared co-authors 2
Suzanne Devkota
David Geffen School of Medicine, University of California Los Angeles
Career Start Year 2010
Number of shared co-authors 3
Joseph J Larson
Division of Clinical Trials and Biostatistics, Mayo Clinic
Career Start Year 2009
Number of shared co-authors 0
Christopher Koh
Clinical Research Section
Career Start Year 2008
Number of shared co-authors 3
Sunjae Lee
Gwangju Institute of Science and Technology
Career Start Year 2007
Number of shared co-authors 0
George F Mells
University of Cambridge
Career Start Year 2006
Number of shared co-authors 0
Peter J Turnbaugh
University of California san francisco
Career Start Year 2005
Number of shared co-authors 6
Ariel D Quiroga
Instituto de Fisiologia Experimental (IFISE)
Career Start Year 2004
Number of shared co-authors 0
Ana Lleo
Humanitas University
Career Start Year 2003
Number of shared co-authors 0
Jonathan P Jacobs
David Geffen School of Medicine at university of california los angeles
Career Start Year 2002
Number of shared co-authors 3
Eran Elinav
German Cancer Research Center
Career Start Year 2002
Number of shared co-authors 6
Gideon M Hirschfield
University of Toronto
Career Start Year 2001
Number of shared co-authors 1
Rohit Kohli
Children's Hospital Los Angeles
Career Start Year 2001
Number of shared co-authors 2
Aimee L Anderson
University of Colorado School of Medicine
Career Start Year 2001
Number of shared co-authors 0
Curtis K Argo
University of Virginia
Career Start Year 2000
Number of shared co-authors 0
Jayant A Talwalkar
Mayo Clinic
Career Start Year 1999
Number of shared co-authors 0
Brian D Juran
Mayo Clinic
Career Start Year 1998
Number of shared co-authors 0
Fedja A Rochling
University of Nebraska Medical Center
Career Start Year 1997
Number of shared co-authors 0
Konstantinos N Lazaridis
Mayo Clinic
Career Start Year 1997
Number of shared co-authors 0
Pietro Invernizzi
Center for Autoimmune Liver Diseases, University of Milano-Bicocca
Career Start Year 1996
Number of shared co-authors 0
Theo Heller
National Institute of Diabetes and Digestive and Kidney Diseases
Career Start Year 1996
Number of shared co-authors 3
Andrew D Clouston
University of Queensland
Career Start Year 1993
Number of shared co-authors 3
Kevin P Rioux
University of Calgary, 0 Hospital Drive NW
Career Start Year 1992
Number of shared co-authors 0
Christine M Hunt
Duke University Medical Center and Durham Veterans Affairs Health Care System
Career Start Year 1990
Number of shared co-authors 1
Grace L Su
University of Washington
Career Start Year 1989
Number of shared co-authors 1
Ramnik J Xavier
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 7
Yoshiyuki Takei
Mie University
Career Start Year 1988
Number of shared co-authors 12
Stephen A Harrison
Pinnacle Clinical Research Center
Career Start Year 1983
Number of shared co-authors 7

Collaborators

David A Brenner
Co-authored papers 51
Peter St??rkel
Cliniques Universitaires Saint-Luc (CUSL)
Co-authored papers 41
Rohit Loomba
Co-authored papers 26
Samuel B Ho
College of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences
Co-authored papers 16
Tatiana Kisseleva
Co-authored papers 16
Ekihiro Seki
Co-authored papers 10
Frank Tacke
Charite-Universitatsmedizin Berlin
Co-authored papers 7
Karen E Nelson
J. Craig Venter Institute, 9605 Medical Center Drive
Co-authored papers 7
Hidekazu Tsukamoto
University of Michigan ann arbor
Co-authored papers 7
David T Pride
University of California San Diego
Co-authored papers 6
Michael Downes
Howard Hughes Medical Institute, Salk Institute for Biological Studies
Co-authored papers 6
Michael Karin
Co-authored papers 6
Ronald M Evans
Co-authored papers 6
Rob Knight
University of California
Co-authored papers 6
Brandon Williams
Vanderbilt University Medical Center
Co-authored papers 4
Ariel E Feldstein
University of California San Diego
Co-authored papers 3
Oliver Fiehn
University of California davis
Co-authored papers 3
Chi-Hua Chen
Center for Multimodal Imaging and Genetics, University of California San Diego
Co-authored papers 3
Wendy Huang
Co-authored papers 3
Nicholas J Schork
University of California San Diego
Co-authored papers 3
Harry Sokol
Paris Center for Microbiome Medicine
Co-authored papers 2
Cameron Martino
Center for Microbiome Innovation, University of California San Diego
Co-authored papers 2
J C Venter
The J. Craig Venter Institute
Co-authored papers 2
Giorgio Trinchieri
Center for Cancer Research, National Cancer Institute, National Institutes of Health
Co-authored papers 2
Samuel W French
Co-authored papers 2
Parambir S Dulai
Feinberg School of Medicine Northwestern University
Co-authored papers 2
Raul Lazaro
Keck School of Medicine of the University of Southern California
Co-authored papers 2
Justine W Debelius
Karolinska Institutet
Co-authored papers 2
Weizhong Li
J. Craig Venter Institute
Co-authored papers 2
Mark A Valasek
Co-authored papers 2
Release 1.2